Claims
- 1. A 1:1 mixture of isomers of formulae: or a salt thereof.
- 2. A pharmaceutical composition comprising a mixture according to claim 1, and a pharmaceutically acceptable carrier.
- 3. A pharmaceutical composition according to claim 2, wherein said pharmaceutically acceptable carrier comprises a carrier for parenteral administration.
- 4. A pharmaceutical composition according to claim 2, wherein said pharmaceutically acceptable carrier comprises a carrier for controlled release administration.
CROSS REFERENCE TO RELATED APPLICATIONS
This application is a continuation of U.S. patent application Ser. No. 09/304,483, filed May 3, 1999 as a continuation of U.S. patent application Ser. No. 08/968,640, now abandoned, filed Nov. 12, 1997 and claims the priority of U.S. Provisional Patent Application Serial No. 60/031,073 filed Nov. 12, 1996. The entire disclosures of the prior applications are incorporated herein by reference.
US Referenced Citations (18)
Foreign Referenced Citations (4)
Number |
Date |
Country |
WO 9319061 |
Sep 1993 |
WO |
WO 9517407 |
Jun 1995 |
WO |
WO 9519983 |
Jul 1995 |
WO |
WO 9629325 |
Sep 1996 |
WO |
Non-Patent Literature Citations (1)
Entry |
Saksena et al., “Concise Asymmetric Routes to 2,2,4-Trisubstituted Tetrahydrofurans Via Chiral Titanium Imide Enolates: Key Intermediates Towards Synthesis of Highly Active Azole Antifungals SCH 51048 and SCH 56592”, Tetrahedron Letters, 37, No. 32, 5657-5660, 1996. |
Provisional Applications (1)
|
Number |
Date |
Country |
|
60/031073 |
Nov 1996 |
US |
Continuations (2)
|
Number |
Date |
Country |
Parent |
09/304483 |
May 1999 |
US |
Child |
09/663992 |
|
US |
Parent |
08/968640 |
Nov 1997 |
US |
Child |
09/304483 |
|
US |